Search company, investor...

Predict your next investment

Venture Capital

Investments

4

About GSM Fund

Headquarters Location

11995 El Camino Real Suite 305

San Diego, California, 92130,

United States

415-448-1212

Want to inform investors similar to GSM Fund about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest GSM Fund News

GSM Fund Group Inc. Announces Completion of Reverse Split and Name Change

Dec 2, 2014

Announces Completion of Reverse Split and Name Change TEMPE, Ariz., Dec. 1, 2014 /PRNewswire/ -- GSM Fund Group Inc. (OTC: IFNXD: PK) (the "Company") announced today it has recently changed its corporate name from "InfoLinx Communications Ltd." to "GSM Fund Group Inc." and also completed a 1:100 reverse split of its outstanding shares of common stock. On November 7, 2014, the Company's Board of Directors and shareholder holding a majority of the Company's outstanding voting rights approved changing the Company's name to GSM Fund Group Inc. and to effect a 100:1 reverse split. Thereafter, the Company filed a Certificate of Amendment with the Nevada Secretary of State to take such actions and submitted a Notice of Corporate Action to FINRA. On November 20, 2014, FINRA informed the Company that such corporate actions would take effect at the open of business on November 21, 2014. The Company also changed its ticker symbol to GSMF, which will take effect twenty (20) business days from November 21, 2014. As a result of the aforementioned reverse split, the Company's capital stock structure and information is as follows: Trading Symbol: IFNXD (for 20 business days starting on November 21, 2014; thereafter, the symbol shall be GSMF). Title and Class of

GSM Fund Investments

4 Investments

GSM Fund has made 4 investments. Their latest investment was in Elcelyx Therapeutics as part of their Series E on October 10, 2015.

CBI Logo

GSM Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/1/2015

Series E

Elcelyx Therapeutics

$40M

No

2

2/19/2015

Series D - II

Subscribe to see more

$99M

Subscribe to see more

10

2/21/2014

Series D

Subscribe to see more

$99M

Subscribe to see more

10

2/14/2013

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/1/2015

2/19/2015

2/21/2014

2/14/2013

Round

Series E

Series D - II

Series D

Series C

Company

Elcelyx Therapeutics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$40M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.